Cargando…

Post-infectious irritable bowel syndrome after a laboratory-proven enteritis

There are scarce data on risk factors for post-infectious irritable bowel syndrome (PI-IBS). The objective of this study was to determine the risk factors of developing PI-IBS following an acute infectious gastroenteritis (AGE) episode in which, by laboratory tests, the etiological agent was isolate...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacob, Teodora, Țățulescu, Doina F., Lupșe, Mihaela S., Dumitrașcu, Dan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464999/
https://www.ncbi.nlm.nih.gov/pubmed/32905134
http://dx.doi.org/10.3892/etm.2020.9018
_version_ 1783577490898288640
author Iacob, Teodora
Țățulescu, Doina F.
Lupșe, Mihaela S.
Dumitrașcu, Dan L.
author_facet Iacob, Teodora
Țățulescu, Doina F.
Lupșe, Mihaela S.
Dumitrașcu, Dan L.
author_sort Iacob, Teodora
collection PubMed
description There are scarce data on risk factors for post-infectious irritable bowel syndrome (PI-IBS). The objective of this study was to determine the risk factors of developing PI-IBS following an acute infectious gastroenteritis (AGE) episode in which, by laboratory tests, the etiological agent was isolated. The study was conducted on patients admitted to a tertiary center of infectious diseases during three consecutive years. The patients were divided into two groups: a group consisting of patients admitted with AGE (with an isolated etiological agent) and a control group consisting of patients admitted for an acute upper respiratory tract infection (URTI). The subjects were recalled in our center 6 months after the admission and were evaluated with Rome III IBS diagnostic questionnaire and Bristol Stool Form Scale. The questionnaires were paper printed and directly filled in by the subjects. The response rate in the case group was 5% and in the control group 100%. The prevalence of PI-IBS was higher in patients with AGE, presenting a relative risk (RR) of 4.16 [95% confidence interval (CI), 1.89-9.17], statistically significant (P<0.001) vs. URTI. From 28 female patients, 22 patients (79%) developed PI-IBS and from 17 male patients, 3 patients (18%) had developed PI-IBS with a risk of 4.4 (95% CI, 1.56-12.65), P<0.001. Regarding the infectious etiology of the AGE, Campylobacter jejuni had the highest risk of developing PI-IBS, RR=1.2 (95% CI, 0.13-3.11), P=0.04 compared with the other agents with a lower risk. The risk to develop PI-IBS after AGE infection is 4.16 higher than after URTI. Female sex is a risk factor for PI-IBS, 79% of the female patients developed PI-IBS after AGE. The incidence of PI-IBS is highest in patients with Campylobacter jejuni AGE compared with the other agents.
format Online
Article
Text
id pubmed-7464999
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74649992020-09-03 Post-infectious irritable bowel syndrome after a laboratory-proven enteritis Iacob, Teodora Țățulescu, Doina F. Lupșe, Mihaela S. Dumitrașcu, Dan L. Exp Ther Med Articles There are scarce data on risk factors for post-infectious irritable bowel syndrome (PI-IBS). The objective of this study was to determine the risk factors of developing PI-IBS following an acute infectious gastroenteritis (AGE) episode in which, by laboratory tests, the etiological agent was isolated. The study was conducted on patients admitted to a tertiary center of infectious diseases during three consecutive years. The patients were divided into two groups: a group consisting of patients admitted with AGE (with an isolated etiological agent) and a control group consisting of patients admitted for an acute upper respiratory tract infection (URTI). The subjects were recalled in our center 6 months after the admission and were evaluated with Rome III IBS diagnostic questionnaire and Bristol Stool Form Scale. The questionnaires were paper printed and directly filled in by the subjects. The response rate in the case group was 5% and in the control group 100%. The prevalence of PI-IBS was higher in patients with AGE, presenting a relative risk (RR) of 4.16 [95% confidence interval (CI), 1.89-9.17], statistically significant (P<0.001) vs. URTI. From 28 female patients, 22 patients (79%) developed PI-IBS and from 17 male patients, 3 patients (18%) had developed PI-IBS with a risk of 4.4 (95% CI, 1.56-12.65), P<0.001. Regarding the infectious etiology of the AGE, Campylobacter jejuni had the highest risk of developing PI-IBS, RR=1.2 (95% CI, 0.13-3.11), P=0.04 compared with the other agents with a lower risk. The risk to develop PI-IBS after AGE infection is 4.16 higher than after URTI. Female sex is a risk factor for PI-IBS, 79% of the female patients developed PI-IBS after AGE. The incidence of PI-IBS is highest in patients with Campylobacter jejuni AGE compared with the other agents. D.A. Spandidos 2020-10 2020-07-16 /pmc/articles/PMC7464999/ /pubmed/32905134 http://dx.doi.org/10.3892/etm.2020.9018 Text en Copyright: © Iacob et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Iacob, Teodora
Țățulescu, Doina F.
Lupșe, Mihaela S.
Dumitrașcu, Dan L.
Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title_full Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title_fullStr Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title_full_unstemmed Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title_short Post-infectious irritable bowel syndrome after a laboratory-proven enteritis
title_sort post-infectious irritable bowel syndrome after a laboratory-proven enteritis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464999/
https://www.ncbi.nlm.nih.gov/pubmed/32905134
http://dx.doi.org/10.3892/etm.2020.9018
work_keys_str_mv AT iacobteodora postinfectiousirritablebowelsyndromeafteralaboratoryprovenenteritis
AT tatulescudoinaf postinfectiousirritablebowelsyndromeafteralaboratoryprovenenteritis
AT lupsemihaelas postinfectiousirritablebowelsyndromeafteralaboratoryprovenenteritis
AT dumitrascudanl postinfectiousirritablebowelsyndromeafteralaboratoryprovenenteritis